Patrick McCall's most recent trade in IN8bio Inc was a trade of 20,492 Series B Warrants (right to buy) done . Disclosure was reported to the exchange on April 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 20,492 | 20,492 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 20,492 | 0 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 27 Apr 2025 | 15,000 | 67,071 | - | 0.2 | 2,766 | Common Stock |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 15,000 | 15,000 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 15,000 | 5,492 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2025 | 15,000 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 343,000 | 343,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 290,085 | 290,085 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 25,316 | - | - | Series C Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 52,071 | - | - | Common Stock | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 20,492 | 20,492 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 20,492 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | McCall Patrick | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 189,000 | 189,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | McCall Patrick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,492 | 20,492 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,492 | 20,492 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | McCall Patrick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,492 | 26,755 | - | - | Common Stock | |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 25 Aug 2023 | 1,000 | 6,263 | - | 1.0 | 1,030 | Common Stock |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 87,150 | 87,150 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 59,796 | 59,796 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 16 Aug 2022 | 5,263 | 5,263 | - | 1.9 | 10,000 | Common Stock |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 84,500 | 84,500 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Patrick McCall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |